Clinical trial
Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile
NCT02216825 is registered in ClinicalTrials.gov with Micropharma Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile
- Lead sponsor
- Micropharma Limited
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- June 30, 2014
- Enrollment
- 10 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.